Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Robinson

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|February 23, 2007
Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinomaMarinella Messina, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|December 13, 2007
Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases?Diana L Learoyd, Bruce G Robinson
Best Practice & Research. Clinical Endocrinology & Metabolism|September 19, 2006
Genetic basis of phaeochromocytoma and paragangliomaDiana E Benn, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|April 25, 2007
Pheochromocytoma-quo vadis?Diana E Benn, Bruce G Robinson
The Medical Journal of Australia|November 6, 2014
The medical workforce of the futureBruce G Robinson, Peter M Brooks
Nature Clinical Practice. Endocrinology & Metabolism|November 13, 2008
Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancerDiana L Learoyd, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|August 25, 2006
Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery?Diana L Learoyd, Bruce G Robinson
The Medical Journal of Australia|February 1, 2003
Responses to access block in Australia: Royal North Shore HospitalRohan J H Hammett, Bruce G Robinson
Autophagy|October 26, 2011
Evolution of the "autophagamiR"Justin S Gundara, Bruce G Robinson, Stan B Sidhu
Clinical & Experimental Ophthalmology|July 30, 2004
External ophthalmic findings in multiple endocrine neoplasia type 2BDouglas G Parker, Bruce G Robinson, Brett A O'Donnell
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Nature Clinical Practice. Endocrinology & Metabolism|February 23, 2007
Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinomaMarinella Messina, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|December 13, 2007
Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases?Diana L Learoyd, Bruce G Robinson
Best Practice & Research. Clinical Endocrinology & Metabolism|September 19, 2006
Genetic basis of phaeochromocytoma and paragangliomaDiana E Benn, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|April 25, 2007
Pheochromocytoma-quo vadis?Diana E Benn, Bruce G Robinson
The Medical Journal of Australia|November 6, 2014
The medical workforce of the futureBruce G Robinson, Peter M Brooks
Nature Clinical Practice. Endocrinology & Metabolism|November 13, 2008
Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancerDiana L Learoyd, Bruce G Robinson
Nature Clinical Practice. Endocrinology & Metabolism|August 25, 2006
Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery?Diana L Learoyd, Bruce G Robinson
The Medical Journal of Australia|February 1, 2003
Responses to access block in Australia: Royal North Shore HospitalRohan J H Hammett, Bruce G Robinson
Autophagy|October 26, 2011
Evolution of the "autophagamiR"Justin S Gundara, Bruce G Robinson, Stan B Sidhu
Clinical & Experimental Ophthalmology|July 30, 2004
External ophthalmic findings in multiple endocrine neoplasia type 2BDouglas G Parker, Bruce G Robinson, Brett A O'Donnell
Pageof 16